Isoflavone [orch, phsu]
Supplementation [topp]
Endothelial [tisu]
function [phsf]
Menopausal [phsf]
Women [popg]
Objective [inpr]
Strong [qlco]
OBSERVATIONAL [resa]
Estrogen [horm, phsu, strd]
Cardiovascular disease [dsyn]
Trial [resa]
Suggest [idcn]
Hormone replacement therapy [topp]
adverse effects [ftcn]
Menopausal [phsf]
Women [popg]
Established [qlco]
coronary heart disease [dsyn]
Isoflavones [orch, phsu]
Estrogen Analogues [orch, phsu]
Plants [plnt]
Estrogen [horm, phsu, strd]
properties [qlco]
Favorable [qlco]
Side Effect [patf]
Profile [lbpr]
Ideal [qlco]
Alternative [cnce]
Hormone replacement therapy [topp]
CARDIOVASCULAR [bdsy]
Benefits [qnco]
Endothelial [tisu]
function [phsf]
Marker [clna]
CARDIOVASCULAR [bdsy]
Health [idcn]
Isoflavones [orch, phsu]
Endothelial [tisu]
function [phsf]
Brachial Artery [bpoc]
Reactive [qlco]
Test [lbpr]
Design [acty]
measurements [ftcn]
twenty [orch, phsu]
Nine [qnco]
Health [idcn]
Menopausal [phsf]
Women [popg]
Entry [inpr]
Exit [spco]
Brachial Artery [bpoc]
REACTIVITY TESTING [ftcn]
Following [tmco]
Randomization [resa]
2 Weeks [tmco]
Oral Concentrate [bodm]
Soy Isoflavone [aapp, phsu]
Containing [ftcn]
mg% [qnco]
SOY ISOFLAVONES [aapp, phsu]
IL [geoa]
USA [geoa]
placebo [topp]
Study [mnob]
Exit [spco]
placebo [topp]
Isoflavone [orch, phsu]
Group [idcn]
Flow [npop]
mediated [socb]
Dilation [patf]
Entry [inpr]
Exit [spco]
Response [orga]
Nitroglycerin [orch, phsu]
subgroup [virs]
Lipid [lipd]
Estrogen Effect [fndg]
Conclusions [idcn]
Suggest [idcn]
Short-term [tmco]
oral supplements [phsu]
Isoflavone [orch, phsu]
Endothelial [tisu]
function [phsf]
Health [idcn]
Menopausal [phsf]
Women [popg]
